Female Gender Is an Independent Prognostic Factor in Non-small-cell Lung Cancer: A Meta-analysis
スポンサーリンク
概要
- 論文の詳細を見る
Purpose: It is not clear whether women with non-small-cell lung cancer (NSCLC) live significantly longer than men. Thus, we conducted a meta-analysis of published studies to quantitatively compare NSCLC survival data between genders.Materials and Methods: A MEDLINE Web search for computer-archived bibliographic data regarding overall survival differences between genders was performed. DerSimonian-Laird random effects analysis was used to estimate the pooled hazard ratio (HR).Results: We selected 39 articles as appropriate data sources, involving 86 800 patients including 32 701 women and 54 099 men. Combined HRs for women vs. men in studies using univariate and multivariate analyses respectively were 0.79 (p <0.0001) and 0.78 (p <0.0001). Pooled HRs for 3 study subgroups having (1) fewer than 30% stage I cases, (2) fewer than 50% adenocarcinoma cases, and (3) statistical adjustment for smoking status all indicated the survival advantage of women.Conclusion: This meta-analysis of published data concerning NSCLC patients indicated significantly better survival for women.
論文 | ランダム
- P-1-464 胃癌における血清腫瘍マーカーとしてのRUNX3プロモーター領域メチル化の定量的検出(胃 研究,一般演題(ポスター),第63回日本消化器外科学会総会)
- 1356 早期類似T2胃癌症例の検討(胃治療2(進行胃癌),一般演題,第61回日本消化器外科学会定期学術総会)
- 胸部下部食道癌における頚部上縦隔リンパ節郭清の有効性の検討(胸部下部食道癌の外科治療はどう変わったか, 第60回日本消化器外科学会総会)
- 8. 胃上部胃癌における胃癌取扱い規約とTNM分類のリンパ節転移度の比較(Session1 上部癌 : リンパ節転移と郭清)(第33回胃外科・術後障害研究会)
- PPB-3-180 切除不能転移性肝癌に対するレンチナンを併用した動注免疫化学療法(I-PMC療法)の試み(転移性肝癌3)